Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13897063 | 0.87 | TSHR (0.37) | TSHRTDP1 | |
| SCHEMBL1298164 | 0.84 | LMNA (0.33) | TSHRLMNA | |
| SCHEMBL5655854 | 0.80 | ALDH1A1 (0.41) | ALDH1A1TRPA1LMNA | |
| SCHEMBL21064215 | 0.78 | TSHR (0.36) | TSHR | |
| Propylene Glycol SCHEMBL10498386 | 0.76 | ALDH1A1 (0.53) | ALDH1A1TSHRLMNATDP1 | |
| SCHEMBL13185947 | 0.76 | ALDH1A1 (0.46) | ALDH1A1TRPA1TSHRLMNATDP1 | |
| SCHEMBL26048705 | 0.75 | ALDH1A1 (0.41) | ALDH1A1TDP1 | |
| SCHEMBL26064529 | 0.75 | — | — | |
| Ethylene Glycol SCHEMBL10498005 | 0.74 | ALDH1A1 (0.52) | ALDH1A1TSHRLMNATDP1 | |
| SCHEMBL25541501 | 0.74 | LMNA (0.32) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11702429-B2 | mTORC modulators and uses thereof | AEOVIAN PHARMACEUTICALS, INC. (US) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702429-B2 | mTORC modulators and uses thereof | MTOR, RICTOR, RPTOR | ALDH1A1 4766/4885TRPA1 4691/4885TSHR 3270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.